EPO antibody (AA 1-166)
Quick Overview for EPO antibody (AA 1-166) (ABIN2450538)
Target
See all EPO AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 1-166
-
Specificity
- Produced by kidney or liver of adult mammals and by liver of fetal or neonatal mammals.
-
Cross-Reactivity (Details)
- No cross reactivity with other proteins.
-
Purification
- Immunogen affinity purified
-
Immunogen
- E. coli-derived human EPO recombinant protein(Position: A1-R166).
-
Isotype
- IgG
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Reconstitution
- Distilled water
-
Concentration
- Lot specific
-
Buffer
- Contains 0.9 mg NaCl, 0.2 mg Na2 HPO4, 0.05 mg sodium azide per 100 μg antibody.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- At -20°C for 1 year. After reconstitution, at 4°C for 1 month. It can also be aliquotted and stored frozen at -20°C for a longer time.Avoid freeze-thaw cycles.
-
-
- EPO (Erythropoietin (EPO))
-
Alternative Name
- Erythropoietin / EPO
-
Target Type
- Hormone
-
Background
-
Name/Gene ID: EPO
Family: Hormone
Synonyms: EPO, Epoetin, EP, MVCD2, Erythropoietin -
Gene ID
- 2056
-
Pathways
- JAK-STAT Signaling, Hormone Activity, Negative Regulation of intrinsic apoptotic Signaling, Negative Regulation of Transporter Activity
Target
-